ACTA2 and glioblastoma: In IDH-wildtype GBM in the TCGA database, the group with high expression of ACTA2 at the time of recurrence (n = 7) had a significantly worse prognosis than the group with low expression (n = 5) (Figure S3C, p = 0.001).